跳至主要内容
临床试验/NCT02839096
NCT02839096Unknown不适用

Once Daily Versus Twice Daily Iron Supplementation to Treat Anemia in Pregnancy: A Prospective, Randomized, Placebo Controlled, Double Blinded, Clinical Trial

University of Missouri-Columbia1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2016年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Hemoglobin

研究概览

简要总结

The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation

详细描述

Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton gestation
  • Iron deficiency anemia as defined by a Hgb of less than 11mg/dL in the first and 3rd trimester and 10.5mg/dL in the 2nd trimester and a serum ferritin of less than 15ug/mL.
  • In accordance with American College of Obstetricians and Gynecologists (ACOG) guidelines, the Hgb cutoff will be reduced by 0.8mg/dL in African American women.
  • In accordance with the standard of care, African American women and those with a mean corpuscular volume (MCV) on their routine screening complete blood count (CBC) of less than 70 will require a hemoglobin electrophoresis to exclude hemoglobinopathy prior to enrollment.

排除标准

  • Multiple gestation
  • Maternal hemoglobinopathy or hemochromatosis,
  • Irritable bowel disease or irritable bowel syndrome
  • History of bariatric surgery or extensive bowel surgery
  • Individuals already receiving iron supplementation aside from prenatal vitamins.

研究组 & 干预措施

Once Daily Dosing

Other

Randomized to 325mg of ferrous sulfate in the morning and placebo in the evening

干预措施: Placebo (Drug)

Once Daily Dosing

Other

Randomized to 325mg of ferrous sulfate in the morning and placebo in the evening

干预措施: Ferrous Sulfate (Drug)

Twice Daily Dosing

Other

Randomized to 325mg of ferrous sulfate in the morning and 325mg of ferrous sulfate in the evening

干预措施: Ferrous Sulfate (Drug)

结局指标

主要结局

Hemoglobin

时间窗: Change in hemoglobin from baseline to one day postpartum

Maternal Hemoglobin will be measured at baseline, at the time of admission for labor and delivery and on post partum day one. Postpartum day 1 hemoglobin was estimated from hematocrit by dividing by 2.941.

Incidence of Gastrointestinal Side Effects (i.e. Constipation, Upset Stomach) as Measured by a Validated Questionnaire

时间窗: From enrollment to delivery, which will be an average of 10-12 weeks

Record the incidence of gastrointestinal side effects (i.e. constipation, upset stomach) as measured by a validated questionnaire.

次要结局

  • Incidence of Blood Transfusion at Delivery(At delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Lee Jackson

Assistant Professor

University of Missouri-Columbia

研究点 (1)

Loading locations...

相似试验